Decapeptyl CR contains triptorelin acetate, which is a gonadotropin-releasing hormone agonist (GnRH), which helps reduce testosterone levels and treat hormone-dependent prostate cancer.
Decapeptyl CR is used to treat:
Prostate cancer.
Precocious puberty in children (girls under 9, boys younger than 10).
Endometriosis in women.
Uterine myoma in women.
The Decapeptyl CR injection is used once every 28 days.
Decapeptyl injection can be administered by subcutaneous injection or intramuscular injection.
The dosage of children varies based on their weight.
Decapeptyl is for use only once, and any remaining contents must be discarded after use.
Decapeptyl CR may cause some side effects, such as:
Hot flushes.
Impotence.
Poor libido.
Gynecomastia and testicular atrophy (rare).
Dry vagina or dyspareunia in women.
Depression.
High levels of liver enzymes.
Decapeptyl CR is not used in case of:
Allergy to drug ingredients.
Suffering from hormone-independent prostate cancer.
Surgical castration.
osteoporosis or an increased risk of osteoporosis.
Pregnancy and lactation.
Brain tumors in children.
Care should be taken before getting a Decapeptyl, especially if you are taking other medications, such as:
Hormonal treatments.
Spironolactone.
Levodopa.
Digoxin.
Keep out of children's reach.
Keep at a temperature of 2-8 degrees Celsius.
It's only transferred in a refrigeration chain.